Results 181 to 190 of about 82,463 (315)

The place of micro and small Enterprises in European Insolvency law

open access: yesInternational Insolvency Review, EarlyView.
Abstract Micro and small enterprises (MSEs) form the backbone of the European economy but remain particularly vulnerable to financial distress and insolvency. Despite the EU's efforts to harmonise insolvency laws, significant divergences persist among Member States, especially regarding tailored frameworks for smaller businesses.
Oleksiy Kononov
wiley   +1 more source

A survey of Australian insolvency practitioners about the moratorium in corporate insolvency and its potential reform

open access: yesInternational Insolvency Review, EarlyView.
Abstract A survey of Australian insolvency practitioners explored the moratorium in corporate insolvency and its potential for reform. Conducted between 18 May and 30 June 2024, the survey targeted 1175 registered liquidators and recognised insolvency lawyers, gathering 119 responses.
Leonard McCarthy
wiley   +1 more source

A developing country's perspective: Reforming insolvency laws to encourage their usage

open access: yesInternational Insolvency Review, EarlyView.
Abstract Opportunities in developing countries draw multinational companies, which include but are not limited to low‐cost labour and abundant raw materials. As with any enterprise in any part of the world, there is a risk of business failure when multinational companies operate in developing countries.
Phoebe Gatoto
wiley   +1 more source

Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling—The CATCH experience

open access: yesInternational Journal of Cancer, EarlyView.
What's New? CATCH is a prospective precision oncology registry trial that harnesses whole‐genome/exome‐ and RNA‐sequencing to enable actionable biomarker detection in metastatic breast cancer patients of any subtype. The data of the first 412 consecutive patients with completed follow‐up in this real‐world, single‐center patient cohort provide robust ...
Mario Hlevnjak   +31 more
wiley   +1 more source

Home - About - Disclaimer - Privacy